This is the text extract for July Tender Notification, browse documents here.

---

30 July 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products included in the Invitation to Tender dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th August 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 September 2010 and Sole Supply Status commences 1 December 2010.

The decisions were as follows:

Chemical Name Captopril Flutamide Haloperidol Haloperidol Haloperidol Haloperidol Haloperidol Hydrocortisone Lignocaine hydrochloride Lignocaine hydrochloride Lignocaine with prilocaine Lignocaine with prilocaine Methotrexate*

Presentation; Pack size and type Oral liq 5 mg per ml; 95 ml bottle OP Tab 250 mg; 100 tablets, blister Inj 5 mg per ml, 1 ml, 10 injections, ampoule Oral liq 2 mg per ml, 100 ml bottle Tab 500 mg; 100 tablets, bottle Tab 1.5 mg; 100 tablets, bottle Tab 5 mg; 100 tablets, bottle Inj 50 mg per ml, 2 ml; 1 injection, vial Inj 1%, 20 ml; 5 injections, vial Inj 1%, 5 ml; 50 injections, vial Crm 2.5% with prilocaine 2.5%, 30 g OP, 1 tube Crm 2.5% with prilocaine 2.5%, 5 g, 5 tubes Inj 25 mg per ml, 2 ml; 5 injections, vial

Current Subsidy $51.04 $48.30 $17.04 $18.06 $4.93 $7.45 $23.49 $3.72 $23.50 $42.00 $41.00 $41.00 $46.10

New tender subsidy $94.99 $55.00 $18.74 $19.87 $5.42 $8.20 $25.84 $3.99 $20.00 $35.00 $45.00 $45.00 $48.00

Sole supply brand (Supplier) Capoten (Sigma) Flutamin (Mylan) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma) Solu-Cortef (Pfizer) Xylocaine (AstraZeneca) Xylocaine (AstraZeneca) EMLA (AstraZeneca) EMLA (AstraZeneca) Hospira (Hospira)

A351394 - qA15909

---

Chemical Name Methotrexate* Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate Morphine tartrate Morphine tartrate Nystatin Nystatin Phenoxymethylpenicillin (Penicillin V) Phenoxymethylpenicillin (Penicillin V) Sodium chloride Sodium citro-tartrate

Presentation; Pack size and type Inj 25 mg per ml, 20 ml; 1 injection, vial Cap long-acting 10 mg; 10 capsules, blister Cap long-acting 30 mg; 10 capsules, blister Cap long-acting 60 mg; 10 capsules, blister Cap long-acting 100 mg; 10 capsules, blister Inj 80 mg per ml, 1.5 ml; 5 injections, ampoule Inj 80 mg per ml, 5 ml; 5 injections, ampoule Cap 500,000 u; 50 capsules, bottle Tab 500,000 u; 50 tablets, bottle Cap potassium salt 250 mg; 50 capsules, blister Cap potassium salt 500 mg; 50 capsules, blister Inj 23.4%, 20 ml; 5 injections, ampoule Grans effervescent 4 g sachets; 28 sachets

Current Subsidy $80.25 $1.80 $2.64 $7.20 $7.85 $20.20 $67.37 $11.64 $9.60 $4.29 $8.15 $26.50 $2.75

New tender subsidy $90.00 $2.22 $3.20 $6.90 $8.05 $30.00 $75.00 $12.81 $14.16 $9.71 $11.70 $31.25 $2.71

Sole supply brand (Supplier) Hospira (Hospira) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) Hospira (Hospira) Hospira (Hospira) Nilstat (Sigma) Nilstat (Sigma) Cilicane VK (Sigma) Cilicane VK (Sigma) Biomed (Biomed) Ural (Arrow)

* The subsidy for methotrexate 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.09 per mg to $0.10 per mg from 1 September 2010.

2. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 September 2010, reference pricing of nontender winning brand will occur on 1 November 2010 and Sole Subsidised Supply commences on 1 February 2011.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Inj 500 mg; 1 injection, vial

Current Subsidy $3.99 $25.00 (28 tablets) $29.50 (per 50 inj)

New tender subsidy $2.57

Sole supply brand (Supplier) Veracol (Multichem) Apo-Clopidogrel (Apotex) Frusemide-Claris (AFT)

Brands (suppliers) affected by reference pricing and delisting AFT (AFT) Arrow-Clopidogrel (Arrow) Plavix (SanofiAventis) Mayne (Hospira) Mucilax (Douglas) Isogel (GSK NZ) Normacol (CSL Biotherapies) Metamucil (Pfizer) Cromolux (AFT) Apo-B-Complex (Apotex)

Ceftriaxone sodium

Clopidogrel

Tab 75 mg; 90 tablets, bottle Inj 10 mg per ml, 2 ml; 5 injections, ampoule

$16.25

Furosemide

$1.30

Mucilaginous laxatives*

Dry; 500 g OP, bottle

$5.72 per 325 g

$6.02

Konsyl-D (Mylan)

Sodium cromoglycate Vitamin B complex

Eye drops 2%; 5 ml OP, bottle Tab, strong BPC; 500 tablets, bottle

$3.95 (per 10 ml) $12.10

$1.18 $4.70

Rex Medical (Rex Medical) B-PlexADE (Boucher and Muir)

A351394 - qA15909

---

Chemical Name

Presentation; Pack size and type

Current Subsidy

New tender subsidy

Sole supply brand (Supplier)

Brands (suppliers) affected by reference pricing and delisting

* Mucilax Dry will be referenced priced and delisted. Mucilax Sugar Free will be referenced priced to the same per g subsidy ($3.31 per 275 g) as Konsyl D however will not be delisted.

3. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 October 2010, reference pricing of nontender winning brand will occur on 1 December 2010 and Sole Subsidised Supply commences on 1 March 2011.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Cap 250 mg; 500 capsules, blister Cap 500 mg; 500 capsules, blister Current Subsidy $17.30 $27.25 New tender subsidy $16.18 $26.50 Sole supply brand (Supplier) Alphamox (Mylan) Alphamox (Mylan) Brands (suppliers) affected by reference pricing and delisting Apo-Amoxi (Apotex) Apo-Amoxi (Apotex)

Amoxycillin Amoxycillin

4. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 December 2010, reference pricing of nontender winning brand will occur on 1 February 2011 and Sole Subsidised Supply commences on 1 May 2011.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Tab 4 mg; 30 tablets, blister Tab 8 mg; 10 tablets, blister Current Subsidy $17.18 (per 10 tablets) $33.89 (per 20 tablets) New tender subsidy $5.10 $1.70 Sole supply brand (Supplier) Dr Reddy's ( Dr Reddy's) Dr Reddy's ( Dr Reddy's) Brands (suppliers) affected by reference pricing and delisting Zofran (GSK) Zofran (GSK)

Ondansetron Ondansetron

5. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 March 2011, reference pricing of non-tender winning brand will occur on 1 May 2011 and Sole Subsidised Supply commences on 1 August 2011.

The decisions were as follows:

Chemical Name Presentation; Pack size and type Tab disp 4 mg; 10 tablets, blister Tab disp 8 mg; 10 tablets, blister Current Subsidy $17.18 (per 10 tablets) $20.43 (per 10 tablets) New tender subsidy $1.70 $2.00 Sole supply brand (Supplier) Dr Reddy's ( Dr Reddy's) Dr Reddy's ( Dr Reddy's) Brands (suppliers) affected by reference pricing and delisting Zofran Zydis(GSK) Zofran Zydis (GSK)

Ondansetron Ondansetron

6. Tenders awarded to an unlisted pharmaceutical – listing for tender winning brand at the tender subsidy will occur on 1 October 2010 and Sole Subsidised Supply commences on 1 March 2011.

The decisions were as follows:

A351394 - qA15909

---

Chemical Name Loperamide hydrochloride

Presentation; Pack size and type Cap 2 mg; 400 capsules, blister

New tender subsidy $8.95

Sole supply brand (Supplier) Diamide Relief (Mylan)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 7. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 September 2010; DV Limits will apply from 1 November 2010

The decisions were as follows:

Chemical Name Dacarbazine* Fluorouracil sodium**

Presentation; Pack size and type Inj 200 mg; 1 injection, vial Inj 50 mg per ml, 10 ml, 1 injection, vial Inj 50 mg per ml, 20 ml, 1 injection, vial Inj 50 mg per ml, 50 ml, 1 injection, vial Inj 50 mg per ml, 100 ml, 1 injection, vial Tab 250 mg; 100 tablets, blister Inj 5 mg per ml, 1 ml, 10 injections, ampoule Oral liq 2 mg per ml, 100 ml bottle Tab 500 mg; 100 tablets, bottle Tab 1.5 mg; 100 tablets, bottle Tab 5 mg; 100 tablets, bottle

Hospital Supply Brand (Supplier) Hospira (Hospira) Fluorouracil Ebewe (InterPharma) Fluorouracil Ebewe (InterPharma) Fluorouracil Ebewe (InterPharma) Fluorouracil Ebewe (InterPharma) Flutamin (Mayne) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma) Serenace (Sigma)

Current pack price $43.86 $24.75 (per 5 vials) $8.60

New pack price $48.00 $5.25

DV Limit 1% 1%

Fluorouracil sodium**

$7.50

1%

Fluorouracil sodium**

$21.50

$18.00

1%

Fluorouracil sodium** Flutamide Haloperidol Haloperidol Haloperidol Haloperidol Haloperidol Lignocaine hydrochloride Lignocaine hydrochloride with adrenaline Lignocaine hydrochloride with adrenaline Lignocaine hydrochloride with adrenaline Lignocaine with prilocaine Lignocaine with prilocaine Lignocaine with prilocaine Mesna***

$43.00 $48.30 $17.04 $18.06 $4.93 $7.45 $23.49 $60.00 $18.00

$34.50 $55.00 $18.74 $19.87 $5.42 $8.20 $25.84 $75.00 $27.00

1% 1% 1% 1% 1% 1% 1% 1% 1%

Pump spray 10%, 50 ml CFC-free; 1 Xylocaine (AstraZeneca) bottle Inj 1% with 1:100,000 adrenaline; 5 ml, 10 injections, vial Xylocaine (AstraZeneca)

Inj 1% with 1:200,000 adrenaline, 20 Xylocaine (AstraZeneca) ml; 5 injections, vial Inj 2% with 1:200,000 adrenaline, 20 Xylocaine (AstraZeneca) ml; 5 injections, vial Crm 2.5% with prilocaine 2.5%, 30 g, 1 tube Crm 2.5% with prilocaine 2.5%, 5 g, 5 tubes Patch 2.5% with prilocaine 2.5%, 20 patches, sachet Inj 100 mg per ml, 4 ml; 15 injections, ampoule EMLA (AstraZeneca) EMLA (AstraZeneca) EMLA (AstraZeneca) Uromitexan (Baxter)

$44.00

$50.00

1%

$49.50 $41.00 $41.00 $104.00 $109.63

$60.00 $45.00 $45.00 $115.00 $137.04

1% 1% 1% 1% 1%

A351394 - qA15909

---

Chemical Name Mesna*** Mesna*** Mesna*** Morphine sulphate Morphine sulphate Morphine sulphate Morphine sulphate Morphine tartrate Morphine tartrate Mucilaginous laxatives Nystatin Nystatin Phenoxymethylpenicillin (Penicillin V) Phenoxymethylpenicillin (Penicillin V) Prilocaine hydrochloride

Presentation; Pack size and type Inj 100 mg per ml, 10 ml; 15 injections, ampoule Tab 400 mg; 50 tablets, blister Tab 600 mg; 50 tablets, blister Cap long-acting 10 mg; 10 capsules, blister Cap long-acting 30 mg; 10 capsules, blister Cap long-acting 60 mg; 10 capsules, blister Cap long-acting 100 mg; 10 capsules, blister Inj 80 mg per ml, 1.5 ml; 5 injections, ampoule Inj 80 mg per ml, 5 ml; 5 injections, ampoule Dry; 500 g, bottle Cap 500,000 u; 50 capsules, bottle Tab 500,000 u; 50 tablets, bottle Cap potassium salt 250 mg; 50 capsules, blister Cap potassium salt 500 mg; 50 capsules, blister Inj 0.5%, 50 ml; 5 injections, vial

Hospital Supply Brand (Supplier) Uromitexan (Baxter) Uromitexan (Baxter) Uromitexan (Baxter) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) m-Eslon (Multichem) Hospira (Hospira) Hospira (Hospira) Konsyl-D (Mylan) Nilstat (Sigma) Nilstat (Sigma) Cilicane VK (Sigma) Cilicane VK (Sigma) Citanest (AstraZeneca) Citanest (AstraZeneca) Naropin (AstraZeneca)

Current pack price $251.73 $168.30 $251.35 $1.80 $2.64 $7.20 $7.85 $20.20 $67.37 $5.72 (per 375 g) $11.64 $9.60 $4.29 $8.15 $80.00 $30.90 $145.20

New pack price $314.66 $210.65 $314.40 $2.22 $3.20 $6.90 $8.05 $30.00 $75.00 $6.02 $12.81 $14.16 $9.71 $11.70 $100.00 $55.00 $198.50

DV Limit 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1% 1%

Prilocaine hydrochloride Inj 2%, 5 ml; 10 injections, polyamp Ropivacaine hydrochloride with fentanyl Ropivacaine hydrochloride with fentanyl Sodium chloride Inf 2 mg per ml with 2 µg of fentanyl per ml, 100 ml; 5 bags Inf 2 mg per ml with 2 µg of fentanyl per ml, 200 ml; 5 bags Inj 23.4%, 20 ml; 5 injections, ampoule

Naropin (AstraZeneca) Biomed (Biomed)

$262.60 $26.50

$270.00 $31.25

1% 1%

*The price and subsidy of dacarbazine (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 September 2010. The subsidy for dacarbazine 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $43.86 per 200 mg to $48.00 per 200 mg from 1 September 2010. **The price and subsidy of fluorouracil sodium (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 September 2010. The subsidy for fluorouracil sodium 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.01 per mg to $0.77 per 100 mg from 1 September 2010. *** The price and subsidy of mesna (PCT only) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 September 2010. The subsidy for mesna 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.02 per mg to $2.29 per 100 mg from 1 September 2010.

8. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 September 2010; DV Limits will apply from 1 November 2010; delisting of the other brand in Section H will occur on 1 November 2010.

The decisions were as follows:

A351394 - qA15909

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier) Veracol (Multichem) Veracol (Multichem)

Current pack price $3.99 $10.50

New pack price $2.57 $4.94

DV Limit 1% 1%

Brand (supplier) to be delisted) AFT (AFT) AFT (AFT) Apo-Clopidogrel (Apotex) 28 tablet pack only Arrow-Clopidogrel (Arrow) Plavix (SanofiAventis) Mayne (Hospira)

Ceftriaxone sodium Inj 500 mg; 1 injection, vial Ceftriaxone sodium Inf 2 g; 1 injection, vial

Clopidogrel

Tab 75 mg; 90 tablets, bottle

Apo-Clopidogrel (Apotex)

$25.00 (Arrow, Apo) $73.38 (Plavix) $29.50 (per 50 inj)

$16.25

1%

Furosemide

Inj 10 mg per ml, 2 ml; 5 injections, ampoule

Frusemide-Claris (AFT)

$1.30

1%

9. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 October 2010; DV Limits will apply from 1 December 2010; delisting of the other brand in Section H will occur on 1 December 2010.

The decisions were as follows:

Chemical Name Amoxycillin Amoxycillin

Presentation; Pack size and type

Hospital Supply Brand (Supplier)

Current pack price $17.30 $27.25

New pack price $16.18 $26.50

DV Limit 1% 1%

Brand (supplier) to be delisted) Apo-Amoxi (Apotex) Apo-Amoxi (Apotex)

Cap 250 mg; 500 capsules, Alphamox (Mylan) blister Cap 500 mg; 500 capsules, Alphamox (Mylan) blister

10. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 December 2010; DV Limits will apply from 1 February 2011; delisting of the other brand in Section H will occur on 1 February 2011.

The decisions were as follows:

Chemical Name Ondansetron Ondansetron

Presentation; Pack size and type Tab 4 mg; 30 tablets, blister Tab 8 mg; 10 tablets, blister

Hospital Supply Brand (Supplier) Dr Reddy's ( Dr Reddy's) Dr Reddy's ( Dr Reddy's)

Current pack price $17.18 (per 10 tablets) $33.89 (per 20 tablets)

New pack price $16.18 $26.50

DV Limit 1% 1%

Brand (supplier) to be delisted) Zofran (GSK) Zofran (GSK)

11. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 March 2011; DV Limits will apply from 1 May 2011; delisting of the other brand in Section H will occur on 1 May 2011.

The decisions were as follows:

Chemical Name Ondansetron Ondansetron

Presentation; Pack size and type Tab disp 4 mg; 10 tablets, blister Tab disp 8 mg; 10 tablets, blister

Hospital Supply Brand (Supplier) Dr Reddy's ( Dr Reddy's) Dr Reddy's ( Dr Reddy's)

Current pack price $17.18 (per 10 tablets) $20.43 (per 10 tablets)

New pack price $1.70 $2.00

DV Limit 1% 1%

Brand (supplier) to be delisted) Zofran Zydis (GSK) Zofran Zydis (GSK)

A351394 - qA15909

---

12. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 September 2010 and DV Limits and DV Pharmaceuticals will apply from 1 November 2010.

The decisions were as follows:

Chemical Name Captopril Hydrocortisone Methotrexate Methotrexate Sodium fluorescein

Presentation; Pack size and type Oral liq 5 mg per ml, 95 ml bottle Inj 50 mg per ml, 2 ml; 1 injection, vial Inj 25 mg per ml, 2 ml, 5 injections, vial Inj 25 mg per ml, 20 ml; 1 injection, vial Inj 100 mg per ml, 5 ml; 12 injections, vial

Hospital Supply Brand (Supplier) Capoten (Sigma) Solu-Cortef (Pfizer) Hospira (Hospira) Hospira (Hospira) Fluorescite (Alcon)

Pack Price $94.99 $3.99 $48.00 $90.00 $125.00

DV Limit 1% 1% 1% 1% 1%

13. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 October 2010 and DV Limits and DV Pharmaceuticals will apply from 1 December 2010.

The decisions were as follows:

Chemical Name Loperamide hydrochloride

Presentation; Pack size and type Cap 2 mg; 400 capsules, blister

Hospital Supply Brand (Supplier) Diamide Relief (Mylan)

Pack Price $8.95

DV Limit 1%

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 04 December 2009.

The decisions were as follows:

Chemical Name Bupivacaine Hydrochloride Bupivacaine Hydrochloride Bupivacaine Hydrochloride Bupivacaine Hydrochloride Bupivacaine Hydrochloride Bupivacaine Hydrochloride Gemfibrozil Lignocaine Hydrochloride Loperamide hydrochloride Lorazepam Lorazepam Metoclopramide Hydrochloride

Line Item Inf 0.125%, 100 ml theatre pack Inf 0.125%, 200 ml theatre pack Inf 0.25%, 100 ml theatre pack Inj 0.375%, 20 ml theatre pack Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Tab 300 mg Inj 0.5%, 5 ml Tab, 2 mg Tab 0.5 mg Inj 4 mg per ml, 1 ml Oral liq 5 mg per 5 ml

A351394 - qA15909

---

Chemical Name Mucilaginous Laxatives Mupirocin Sirolimus Sirolimus Sirolimus Tacrolimus

Line Item Sugar free Nasal oint 2% Tab 1 mg Tab 2 mg Oral liq 1 mg per ml Inj 5 mg

For the remaining products on the Invitation to Tender dated 23 December 2008 and the Invitation to Tender dated 4 December 2009 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A351394 - qA15909